Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism
Cari M. Kitahara(National Institutes of Health), Dale L. Preston(ISCO International (United States)), Julie Ann Sosa(Golden Gate University), André Bouville(University of Pisa), Amy Berrington de González(Institute of Cancer Research), Steven L. Simon(National Institutes of Health), Mark Tülchinsky(University of Washington), Michele M. Doody(National Institutes of Health), A.B. Brill(Argonne National Laboratory), Dunstana Melo, Daphnée Villoing(Institut de Cancérologie de l'Ouest)
Cited by 175
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
|Nature Genetics|2009|546
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
|Journal of Clinical Oncology|2010|517